Table 9. Genotype and association analysis of selected candidate genes with androstenone.

Polymorphism	Boar taint compound [Ln(µg/g)]	Genotype (μ ± S.E.)			Effect (μ ± S.E.)
		GG	GA	AA	Additive	Dominance
IRG6 G>A	Androstenone	4.93±0.30c	5.95±0.21d	5.82±0.10d	−0.44±0.15**	−0.57±0.23*
		CC	CT	TT
DSP C>T	Androstenone	5.76±0.21	6.06±0.18	5.94±0.20	−0.09±0.08	−0.20±0.13
		CC	CT	TT
MX1 C>T	Androstenone	5.73±0.12a	5.92±0.11a	5.30±0.18b	0.21±0.11	−0.40±0.14**
		GG	GT	TT
IFIT2 G>T	Androstenone	6.27±0.18a	5.63±0.18b	5.61±0.10b	0.32±0.09**	0.31±0.19
		GG	GA	AA
FMO5 G>A	Androstenone	5.96±0.27a	5.48±0.27b	5.97±0.20a	0.01±0.15	0.47±0.20*
		AA	AG	GG
CYP7A1 A>G	Androstenone	4.63±0.32a	5.60±0.22b	5.73±0.08b	−0.55±0.16 **	−0.42±0.26
		GG	GA	AA
KRT18 G>A	Androstenone	5.70±0.01c	5.82±0.23c	4.59±0.30d	−0.55±0.15 **	−0.66±0.25*

a,b <0.05; c,d<0.01; e,f <0.001;

^*p<0.05;

^**p<0.01.